18-Sep-2007 | research and development
Helix BioPharma awarded U.S. Patent for DOS47 adjunct chemotherapy applications
Helix BioPharma Corp. announced the issuance of its second DOS47 patent (U.S. Patent No. 7,264,800) from the United States Patent & Trademark Office, ...